Omar is retiring. A quick look back at how he transformed Medtronic into the world’s largest medtech company. |

Omar is retiring. A quick look back at how he transformed Medtronic into the world’s largest medtech company.

Here’s how Omar Ishrak transformed Medtronic into the world’s largest medtech operation (MassDevice)

Omar Ishrak used a series of M&A moves and focus on global markets and value-based care to transform Medtronic (NYSE:MDT) into the world’s largest medical device business in less than a decade.

Ishrak is preparing to retire from the corner office next year ahead of the medtech giant’s mandatory retirement age, to be replaced my longtime lieutenant Geoff Martha. Hired in May 2011, Ishrak doubled annual revenues and added $100 billion to Medtronic’s market cap, according to lead director and Textron CEO Scott Donnelly.

Although early turns toward global markets and value-based healthcare were sustained over the course of his nearly decade-long run, Ishrak will be most widely remembered for the largest-ever medtech merger – the $50 billion buyout of Covidien in early 2015 –  and the raft of other M&A moves that defined his time at Medtronic.

His influence over the company will extend past his last day as CEO on April 26, 2020, when he’s due to assume the newly created executive chairmanship the next day. Apart from having a hand-picked successor take over, his new role entails providing “counsel and guidance to Medtronic’s leadership, oversee CEO succession, and drive the ongoing successful execution of Medtronic’s long-term strategic plan.”

Here’s a closer look at the at least $56.02 billion Medtronic spent on acquisitions under Ishrak’s watch (not to mention the $6.48 billion he brought in by selling company assets):

TransactionDateValue
Buys Titan SpineJune 27, 2019undisclosed
Buys Epix TherapeuticsJune 24, 2019$316 million
Sells Responsive OrthopedicsMay 9, 2019undisclosed
Sells stake in LifeTech ScientificMay 7, 2018undisclosed
Buys Mazor RoboticsDec. 19, 2018$1.7 billion
Buys QT Vascular’s Chocolate PTAJan. 30, 2018$28 million
Buys CrosponDec. 11, 2017$45 million
Sells patient care businessJuly 31, 2017$6 billion
Buys HeartWareAugust 23, 2016$1 billion
Buys Smith & Nephew’s TruclearAugust 8, 2016$350 million
Buys Responsive OrthopedicsJune 8, 2016undisclosed
Buys BellcoFeb. 1, 2016undisclosed
Buys Baylis Medical’s OsteoCoolJan. 13, 2016undisclosed
Buys Aircraft MedicalNov. 18, 2015$110 million
Buys Twelve Inc.Oct. 5, 2015$458 million
Buys Lazarus EffectSept. 28, 2015$100 million
Buys Medina MedicalSept. 1, 2015$150 million
Buys RF Surgical SolutionsJuly 13, 2015$235 million
Buys Aptus EndoJune 19, 2015$110 million
Buys CardioInsightJune 19, 2015$93 million
Buys DiabeterApril 2, 2015undisclosed
Buys SophonoMarch 26, 2015undisclosed
Buys CovidienJan. 26, 2015$50 billion
Buys NGC MedicalAugust 27, 2014$350 million
Sells Pillar PalatalFeb. 14, 2014undisclosed
Buys TyrxJan. 6, 2014$160 million
Buys China Kanghui HoldingsNov. 1, 2012$816 million
Sells Physio-ControlJan. 30, 2012$478 million